A Study of the Impact of Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation Donors on Recipients' Post-Transplant Survival Outcomes: A Multicenter Retrospective Cohort Study Based on HIS Data
Sponsor study identifier
observational
1,000
1 country
6
Study Start
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
To investigate the impact of abnormal glucose tolerance in hematopoietic stem cell transplantation donors on patients' post-transplant survival outcomes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 13, 2024
Actual (reported)November 26, 2024
Actual (reported)April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Overall Survival (OS)
Patient's overall survival time since hematopoietic stem cell transplantation
One year-overall survival since hematopoietic stem cell transplantation
Non-relapse Mortality (NRM)
One year since hematopoietic stem cell transplantation
Relapse-free Survival (RFS)
One year since hematopoietic stem cell transplantation
Event-free Survival (EFS)
One year since hematopoietic stem cell transplantation
Graft versus Host Disease (GvHD) incidence
One year since hematopoietic stem cell transplantation
GvHD and Relapse-free Survival (GRFS)
One year since hematopoietic stem cell transplantation
patients who underwent allogeneic hematopoietic stem cell transplantation from March 2019 to March 2024; donor fasting blood glucose and/or HbA1c data available; fasting blood glucose ≥6.1 mmol/L or HbA1c ≥5.7%
patients who underwent allogeneic hematopoietic stem cell transplantation from March 2019 to March 2024; donor fasting blood glucose and/or HbA1c data available; fasting blood glucose \<6.1 mmol/L; HbA1c \<5.7% (if available)
Patients who were diagnosed with hematological disorders and underwent allo-HSCT
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Tongji Hospital of Huazhong University of Science and Technology, Wuhan
Wuhan, Hubei, China
Li Quan Hospital
Shanghai, Shanghai Municipality, China
1\. Peripheral blood/bone marrow specimens from post-transplant patients. 2. Peripheral blood stem cell grafts from donors.
Jingtao Huang
Ruijin Hospital
First Submitted
November 13, 2024
First Posted
November 26, 2024
Study Start
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
Contact the study team to confirm eligibility.
Ruijin Hospital of Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
The First Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Hospital of Hematology of the Chinese Academy of Medical Sciences
Tianjin, China
April 2025
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 26, 2024
Record last verified: 2024-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: